Skip to content
  1. Home
  2. Latest news
  3. Health & wellness
  4. Freedom of breath, fountain of life: How a first-of-its-kind partnership has saved thousands of babies in China

Freedom of breath, fountain of life: How a first-of-its-kind partnership has saved thousands of babies in China

Helping Babies Breathe

A quadruplet baby from the Shen family who needed neonatal resuscitation at birth

Childbirth should be a moment to celebrate the miracle of life, but as many as 1 in 10 newborns are unable to breathe upon entering the world.

The condition, known as birth asphyxia, is among the world’s leading causes of infant death. And a decade ago, it accounted for 20% of China’s infant mortality rate—that’s a shocking 73,000 babies lost each year.

But a simple, low-tech medical technique called neonatal resuscitation can help prevent it. That’s why Johnson & Johnson partnered with the Chinese Ministry of Health and other organizations in an effort to ensure that caregivers in every Chinese hospital received the training they needed to administer the procedure.

Ten years later, we’re proud to say that this unique public/private partnership, known as “Freedom of Breath, Fountain of Life,” has helped over 100,000 Chinese babies take their first breath. And after a decade of success, we’re committed to keeping the partnership going for another five years.

But don’t just take our word for it: Watch the moving video below and meet six kids who are alive and thriving, thanks to the historic partnership that empowered everyone from midwives to doctors to save precious lives.

hqdefault.jpg
Celebrating Life, One Breath at a Time

More from Johnson & Johnson

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

This scientist develops targeted treatments for cancer—here’s what drives and inspires him

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.